Scholz J, Steinhöfel U, Dürig M, Prause A, Bause H W, Hamper K, Schulte am Esch J
Abteilung für Anästhesiologie, Universitäts-Krankenhaus Eppendorf, Hamburg.
Clin Investig. 1993 Apr;71(4):294-8. doi: 10.1007/BF00184730.
There are recent reports on postoperative pulmonary complications in patients with esophageal cancer who were treated preoperatively with chemotherapy and irradiation. The Hamburg Esophageal Study Group is currently undertaking a prospective randomized study to evaluate the efficacy of preoperative treatment. Postoperative pulmonary complications and mortality in these patients with either a combined preoperative treatment (group 1, n = 11) or chemotherapy alone (group 2, n = 9) are evaluated in the present paper. Complete remission of the tumor was found more often in group 1 (54.6%) than in group 2 (22.2%). However, postoperatively the patients of group 1 developed adult respiratory distress syndrome (ARDS; 54.6%) more frequently than in group 2 (11.1%), and all patients with ARDS died. Thus, although the combined preoperative treatment is more effective in tumor remission, it is associated with a higher respiratory failure and postoperative mortality. Therefore, the preoperative regime has now been changed by the study group. Since after the clinical manifestation of ARDS no causative clinical therapy is available up to now, attention must be focused on the prevention of respiratory failure.
近期有关于接受术前化疗和放疗的食管癌患者术后肺部并发症的报道。汉堡食管癌研究小组目前正在进行一项前瞻性随机研究,以评估术前治疗的疗效。本文评估了这些接受术前联合治疗(第1组,n = 11)或单纯化疗(第2组,n = 9)的患者的术后肺部并发症及死亡率。第1组(54.6%)肿瘤完全缓解的发生率高于第2组(22.2%)。然而,术后第1组患者发生成人呼吸窘迫综合征(ARDS;54.6%)的频率高于第2组(11.1%),且所有ARDS患者均死亡。因此,尽管术前联合治疗在肿瘤缓解方面更有效,但它与更高的呼吸衰竭和术后死亡率相关。因此,研究小组现已改变了术前治疗方案。由于迄今为止,ARDS临床表现出现后尚无有效的临床治疗方法,所以必须将注意力集中在预防呼吸衰竭上。